These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
496 related articles for article (PubMed ID: 16829749)
1. Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects. Solomon R; Dumouchel W Invest Radiol; 2006 Aug; 41(8):651-60. PubMed ID: 16829749 [TBL] [Abstract][Full Text] [Related]
2. The role of osmolality in the incidence of contrast-induced nephropathy: a systematic review of angiographic contrast media in high risk patients. Solomon R Kidney Int; 2005 Nov; 68(5):2256-63. PubMed ID: 16221227 [TBL] [Abstract][Full Text] [Related]
3. Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004). DuMouchel W; Fram D; Yang X; Mahmoud RA; Grogg AL; Engelhart L; Ramaswamy K Ann Clin Psychiatry; 2008; 20(1):21-31. PubMed ID: 18297583 [TBL] [Abstract][Full Text] [Related]
5. N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials. Zagler A; Azadpour M; Mercado C; Hennekens CH Am Heart J; 2006 Jan; 151(1):140-5. PubMed ID: 16368307 [TBL] [Abstract][Full Text] [Related]
6. What are radiologists doing to prevent contrast-induced nephropathy (CIN) compared with measures supported by current evidence? A survey of European radiologists on CIN associated with computed tomography. Fishman EK; Reddan D Acta Radiol; 2008 Apr; 49(3):310-20. PubMed ID: 18365820 [TBL] [Abstract][Full Text] [Related]
7. The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials. Reed M; Meier P; Tamhane UU; Welch KB; Moscucci M; Gurm HS JACC Cardiovasc Interv; 2009 Jul; 2(7):645-54. PubMed ID: 19628188 [TBL] [Abstract][Full Text] [Related]
8. The safety and cost-effectiveness of low osmolar contrast media. Can economic analysis determine the real worth of a new technology? Henry DA; Evans DB; Robertson J Med J Aust; 1991 Jun; 154(11):766-72. PubMed ID: 1828529 [TBL] [Abstract][Full Text] [Related]
9. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials. Heinrich MC; Häberle L; Müller V; Bautz W; Uder M Radiology; 2009 Jan; 250(1):68-86. PubMed ID: 19092091 [TBL] [Abstract][Full Text] [Related]
10. [Contrast-induced nephropathy in coronarography of patients with type 2 diabetes mellitus: risk factors, prognostic significance, prophylactic approaches]. Shamkhalova MSh; Zaĭtseva NV; Kurumova KO; Shestakova MV; Deev AD; Matskeplishvili ST; Tugeeva EF; Buziashvili IuI Ter Arkh; 2009; 81(8):36-42. PubMed ID: 19799198 [TBL] [Abstract][Full Text] [Related]
11. Contrast media induced nephropathy: definition, incidence, outcome, pathophysiology, risk factors and prevention. Feldkamp T; Kribben A Minerva Med; 2008 Apr; 99(2):177-96. PubMed ID: 18431326 [TBL] [Abstract][Full Text] [Related]
12. Effect of nonionic radiocontrast agents on the occurrence of contrast-induced nephropathy in patients with mild-moderate chronic renal insufficiency: pooled analysis of the randomized trials. Sharma SK; Kini A Catheter Cardiovasc Interv; 2005 Jul; 65(3):386-93. PubMed ID: 15926184 [TBL] [Abstract][Full Text] [Related]
13. Comparative Effect of Contrast Media Type on the Incidence of Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis. Eng J; Wilson RF; Subramaniam RM; Zhang A; Suarez-Cuervo C; Turban S; Choi MJ; Sherrod C; Hutfless S; Iyoha EE; Bass EB Ann Intern Med; 2016 Mar; 164(6):417-24. PubMed ID: 26830055 [TBL] [Abstract][Full Text] [Related]
14. Contrast-induced nephropathy in patients with diabetes mellitus between iso- and low-osmolar contrast media: A meta-analysis of full-text prospective, randomized controlled trials. Han XF; Zhang XX; Liu KM; Tan H; Zhang Q PLoS One; 2018; 13(3):e0194330. PubMed ID: 29558481 [TBL] [Abstract][Full Text] [Related]
15. Radiologists' knowledge and perceptions of the impact of contrast-induced nephropathy and its risk factors when performing computed tomography examinations: a survey of European radiologists. Reddan D; Fishman EK Eur J Radiol; 2008 May; 66(2):235-45. PubMed ID: 17728089 [TBL] [Abstract][Full Text] [Related]
16. Iodixanol versus low-osmolar contrast media for prevention of contrast induced nephropathy: meta-analysis of randomized, controlled trials. From AM; Al Badarin FJ; McDonald FS; Bartholmai BJ; Cha SS; Rihal CS Circ Cardiovasc Interv; 2010 Aug; 3(4):351-8. PubMed ID: 20647563 [TBL] [Abstract][Full Text] [Related]
17. Renal protective effects and the prevention of contrast-induced nephropathy by atrial natriuretic peptide. Morikawa S; Sone T; Tsuboi H; Mukawa H; Morishima I; Uesugi M; Morita Y; Numaguchi Y; Okumura K; Murohara T J Am Coll Cardiol; 2009 Mar; 53(12):1040-6. PubMed ID: 19298916 [TBL] [Abstract][Full Text] [Related]
18. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Dangas G; Iakovou I; Nikolsky E; Aymong ED; Mintz GS; Kipshidze NN; Lansky AJ; Moussa I; Stone GW; Moses JW; Leon MB; Mehran R Am J Cardiol; 2005 Jan; 95(1):13-9. PubMed ID: 15619387 [TBL] [Abstract][Full Text] [Related]
19. Contrast-induced nephropathy among Israeli hospitalized patients: incidence, risk factors, length of stay and mortality. Shema L; Ore L; Geron R; Kristal B Isr Med Assoc J; 2009 Aug; 11(8):460-4. PubMed ID: 19891232 [TBL] [Abstract][Full Text] [Related]
20. [Tolerability of nonionic contrast media--results of a multicenter double blind study]. Schmiedel E Aktuelle Radiol; 1992 May; 2(3):148-52. PubMed ID: 1610929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]